SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fischer Medical Ventures informs about outcome of board meeting

30 May 2026 Evaluate

Pursuant to Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Fischer Medical Ventures has informed that the Board of Directors of the Company, at its meeting held on 29th May considered and recommended a final dividend of 5% i.e. Rs. 0.05/- per equity share of face value Re. 1/- each for the financial year ended 31st March 2026. The said dividend, if declared and approved by the members at the ensuing Annual General Meeting (‘AGM’), shall be paid/dispatched within 30 days from the date of the AGM.

The above information is a part of company’s filings submitted to BSE. 

Fischer Medical Share Price

33.69 0.75 (2.28%)
04-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 247.05
Amrapali Industries 18.64
Adani Enterprises 2972.80
Rashi Peripheral 539.45
PDS 319.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×